Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccine-Reference-Cited by-同舟云学术

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccine

Published:2003-05 Issue:2 Volume:128 Page:195-204
ISSN:0166-6851
Container-title:Molecular and Biochemical Parasitology
language:en
Short-container-title:Molecular and Biochemical Parasitology

Author:

Angov Evelina,Aufiero Barbara M.,Turgeon Ann Marie,Van Handenhove Michel,Ockenhouse Christian F.,Kester Kent E.,Walsh Douglas S.,McBride Jana S.,Dubois Marie-Claude,Cohen Joe,Haynes J.David,Eckels Kenneth H.,Heppner D.Gray,Ballou W.Ripley,Diggs Carter L.,Lyon Jeffrey A.

Publisher

Elsevier BV

Subject

Molecular Biology,Parasitology

Reference37 articles.

1. World Health Organization. World malaria situation in 1994. Wkly Epidemiol Rec 1997;72:269–76.

2. Gamma globulin and acquired immunity to malaria;Cohen;Nature,1964

3. The major merozoite surface protein as malaria vaccine target;Diggs;Parasitol. Today,1993

4. Acylation of a Plasmodium falciparum merozoite surface antigen via sn-1,2-diacylglycerol;Haldar;J. Biol. Chem.,1985

5. Protective antigens of rodent and human bloodstage malaria;Holder;Phil. Trans. R. Soc. Lond. B. Biol. Sci.,1984

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Harmala Alkaloids as Novel Antimalarial Agents againstPlasmodium falciparumthrough Bioinformatics Approaches;2024-07-18

2. A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults;Vaccine;2024-04

3. Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso;Infection and Immunity;2023-10-17

4. Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA);Frontiers in Immunology;2022-09-22

5. Insights on the emerging biotechnology of histidine-rich peptides;Biotechnology Advances;2022-01